RMAH — Farmaceutica Remedia SA Cashflow Statement
0.000.00%
- RON62.44m
- RON15.66m
- RON743.79m
- 61
- 97
- 42
- 79
Annual cashflow statement for Farmaceutica Remedia SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | PRESS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -13.5 | 2.63 | -1.99 | 23.2 | 19 |
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -13.5 | 2.63 | -1.99 | 23.2 | 19 |
Capital Expenditures | -0.08 | -0.037 | -0.038 | -1.38 | -1.79 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 40 | 0.62 | 0.278 | 0.414 | 2.41 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 39.9 | 0.584 | 0.24 | -0.969 | 0.622 |
Financing Cash Flow Items | 0.024 | 0.008 | -0.055 | -0.005 | -0.138 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2.29 | -13.3 | -4.52 | -5.7 | -6.43 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 24.1 | -10.1 | -6.13 | 16.4 | 13.2 |